MIRA Pharmaceuticals Reports Successful Formulation Results for SKNY-1, Its Oral Drug Candidate for Obesity and Addiction
Go back to MIRA Pharmaceuticals Reports Successful Formulation Results for SKNY-1, Its Oral Drug Candidate for Obesity and Addiction| Miracle Applications Corp (NASDAQ: MIRA) | Delayed: 0.75 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.75 | 52 Week High | $0.04 | |||
| Open | $0.75 | 52 Week Low | $0.00 | |||
| Day High | $0.75 | P/E | N/A | |||
| Day Low | $0.74 | EPS | $0.00 | |||
| Volume | 8,018 | |||||
